C4 Therapeutics Inc

XNAS: CCCC

Weak Stock

Download real time

2.12 -0.07 (-3.20%)

75.20% Fall from 52W High

911.8K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

150.5

Market Cap

Below industry Median

-0.3

Beta 1Year

Very Low volatility

C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 10 analysts

C4 Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of -39.6%, and profit growth estimate of -44.0% for FY25, based on top 10 analyst calls.

Forecaster Screeners